AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 67 filers reported holding AMRYT PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,629,137 | +5.5% | 2,277,964 | 0.0% | 0.18% | +0.6% |
| Q3 2022 | $15,764,000 | -1.0% | 2,277,964 | 0.0% | 0.18% | +23.9% |
| Q2 2022 | $15,923,000 | -15.5% | 2,277,964 | 0.0% | 0.14% | -6.0% |
| Q1 2022 | $18,839,000 | -23.4% | 2,277,964 | 0.0% | 0.15% | -19.7% |
| Q4 2021 | $24,602,000 | -10.3% | 2,277,964 | 0.0% | 0.19% | -11.3% |
| Q3 2021 | $27,438,000 | -0.7% | 2,277,964 | 0.0% | 0.21% | +1.0% |
| Q2 2021 | $27,632,000 | -13.5% | 2,277,964 | -0.6% | 0.21% | -16.3% |
| Q1 2021 | $31,930,000 | +13.2% | 2,292,164 | +15.1% | 0.25% | 0.0% |
| Q4 2020 | $28,196,000 | -0.5% | 1,991,259 | -13.2% | 0.25% | -20.3% |
| Q3 2020 | $28,344,000 | – | 2,293,180 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |